abstract |
The present disclosure provides compounds that are tyrosine kinase inhibitors, in nparticular Bruton tyrosine kinase ("BTK") inhibitors, and are therefore useful for the ntreatment of diseases treatable by inhibition of BTK such as cancer, autoimmune, n5 inflammatory, and thromboembolic diseases. Also provided are pharmaceutical ncompositions containing such compounds and processes for preparing such compounds. |